DOT examinations: Practical aspects and regulatory review

American Family Physician

Volumn 58, Issue 2, 1998, Pages 415-426

  Pommerenke, Forrest ^a   Hegmann, Kurt ^b   Hartenbaum, Natalie P ^c  

^a Rapides Industrial Medicine   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Conrail ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BORDERLINE HYPERTENSION; CERTIFICATION; CHRONIC DISEASE; DIABETES MELLITUS; DRIVING ABILITY; HEARING IMPAIRMENT; HUMAN; MEDICAL SPECIALIST; PHYSICIAN; RESPONSIBILITY; SCREENING; TRAFFIC ACCIDENT; VISUAL IMPAIRMENT;

ACCIDENTS, TRAFFIC; AUTOMOBILE DRIVING; HUMANS; PHYSICAL EXAMINATION; PRACTICE GUIDELINES; UNITED STATES;

EID: 0031856028     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Federal Motor Carrier Safety Regulations, 49 CFR, Part 391.41-49; Subpart E - Physical Qualifications and Examination. U.S. Department of Transportation, 1997.
2. Wharton Transport Corp. v. Bridges. Supreme Court of Tennessee. 606 S.W. 2d 521, 1980.
3. Conference on Cardiac Disorders and Commercial Drivers. Washington, D.C.: U.S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1987. Publication no. FHWA-MC-88-040.
4. Conference on Neurological Disorders and Commercial Drivers. Washington, D.C.: U.S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1988. Publication no. FHWA-MC-88-042.
5. Conference on Psychiatric Disorders and Commercial Drivers. Washington, D.C.: U.S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1991. Publication no. FHWA-MC-91-006.
6. Conference on Respiratory/Pulmonary Disorders and Commercial Drivers. Washington, D.C.: U.S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1991. Publication no. FHWA-MC-91-004.
7. Conference on Diabetic Disorders and Commercial Drivers. Washington, D.C.: U.S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1988. Publication no. FHWA-MC-88-041.
8. LaPorte RE. Insulin-using commercial motor vehicle drivers. Washington, D.C.: U. S. Department of Transportation, Federal Highway Administration, Office of Motor Carriers, 1992. Publication no. FHWA-MC 92-012.
9. Zondag T. DOT Medical certification process. Presented at the American Occupational Health Conference, San Antonio, May 1996.
10. Hartenbaum NP, ed. The DOT medical examination: a guide to commercial drivers' medical certification. Beverly Farms, Mass.: OEM Health Information, 1997.
11. Perry GF. Bus driving after non-Q-wave myocardial infarction. J Occup Med 1994;36:117-8.
12. Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, et al. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions. JAMA 1994; 271:1335-9.
13. Krumholz A, Fisher RS, Lesser RP, Hauser WA. Driving and epilepsy. A review and reappraisal. JAMA 1991;265:622-6.
14. Pakola SJ, Dinges DF, Pack AI. Review of regulations and guidelines for commercial and noncommercial drivers with sleep apnea and narcolepsy. Sleep 1995;18:787-96.
15. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9.
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.